Inici › Malaltia de Crohn › Texas › Tyler
Assaigs clínics de Malaltia de Crohn a Tyler, TX
16 estudis de Malaltia de Crohn busquen participants en centres de Tyler i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
ReclutantFase 3
- Tyler Research Institute ( Site 0294), Tyler
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
ReclutantFase 3
- Tyler Research Institute ( Site 5001), Tyler
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
ReclutantFase 2
- Tyler Research Institute /ID# 265545, Tyler
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- The University of Texas Health Science Center at Tyler, Tyler
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 2/3
- Tyler Research Institute, LLC, Tyler
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 2
- Tyler Research Institute, LLC, Tyler
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
ReclutantFase 3
- Tyler Research Institute, Tyler
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- Tyler Research Institute, LLC-Site Number: 8400095, Tyler
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- Tyler Research Institute LLC-Site Number: 8400095, Tyler
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
ReclutantFase 2
- Tyler Research Institute, LLC, Tyler
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
ReclutantFase 4
- Tyler Research Institute, LLC, Tyler
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- Tyler Research Institute, LLC, Tyler
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
ReclutantFase 3
- Tyler Research Institute, LLC, Tyler
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
ReclutantFase 2
- Tyler Research Institute, LLC, Tyler
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
ReclutantFase 2
- Tyler Research Institute, LLC, Tyler
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
ReclutantFase 2
- Mirador Therapeutics Selected Site, Tyler
Assaigs de Malaltia de Crohn en altres ciutats
- New York City, NY35 estudis
- Cleveland, OH19 estudis
- St. Louis, MO19 estudis
- Boston, MA19 estudis
- Miami, FL19 estudis
- Orlando, FL17 estudis
- Houston, TX17 estudis
- Atlanta, GA17 estudis
- San Diego, CA15 estudis
- San Antonio, TX15 estudis
- Los Angeles, CA15 estudis
- Philadelphia, PA13 estudis
Altres estudis a Tyler
- Càncer de pulmó de cèl·lules no petites20 estudis
- Colitis ulcerosa14 estudis
- Càncer colorrectal8 estudis
- Insuficiència cardíaca8 estudis
- Càncer (tots els tipus)7 estudis
- Càncer d'ovari7 estudis
- Càncer d'endometri6 estudis
- Carcinoma de cèl·lules escamoses de cap i coll6 estudis
- Càncer de mama6 estudis
- Càncer metastàtic5 estudis
- Malaltia inflamatòria intestinal5 estudis
- Leucèmia limfàtica crònica5 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.